Publications by authors named "M Pelayo"

Background: Glioblastoma (GBM) has a median survival of <2 years. Pexidartinib (PLX3397) is a small-molecule inhibitor of CSF1R, KIT, and oncogenic FTL3, which are implicated in GBM treatment resistance. Results from glioma models indicate that combining radiation therapy (RT) and pexidartinib reduces radiation resistance.

View Article and Find Full Text PDF

This article comments on: Segura M, García A, Gamarra G, Benítez A, Iglesias-Moya J, Martínez C, Jamilena M. 2024. An -resistant mutation in the transcription factor gene enhances carpel arrest and ectopic boundary specification in flower development.

View Article and Find Full Text PDF

In angiosperms, the transition from floral-organ maintenance to abscission determines reproductive success and seed dispersion. For petal abscission, cell-fate decisions specifically at the petal-cell base are more important than organ-level senescence or cell death in petals. However, how this transition is regulated remains unclear.

View Article and Find Full Text PDF

The intricate morphology of the flower is primarily established within floral meristems in which floral organs will be defined and from where the developing flower will emerge. Floral meristem development involves multiscale-level regulation, including lineage and positional mechanisms for establishing cell-type identity, and transcriptional regulation mediated by changes in the chromatin environment. However, many key aspects of floral meristem development remain to be determined, such as: 1) the exact role of cellular location in connecting transcriptional inputs to morphological outcomes, and 2) the precise interactions between transcription factors and chromatin regulators underlying the transcriptional networks that regulate the transition from cell proliferation to differentiation during floral meristem development.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates ultrasound features of adnexal masses that are challenging to classify as benign or malignant, using various ultrasound scoring systems.
  • A total of 133 adnexal masses were analyzed, revealing that 66.2% were benign and 33.8% malignant, with ultrasound assessments correctly identifying malignant lesions in all cases.
  • Some borderline tumors and specific malignant types were not consistently detected across ultrasound scores, leading to misclassification of several benign lesions due to certain features like solid areas or papillae.
View Article and Find Full Text PDF